EVALUATE THE FETO-MATERNAL OUTCOMES AND INDICATORS OF ROBSON GROUP 1 CASES RECEIVING CAESAREAN SECTION. (2022). International Research Journal of Pharmacy, 13(6), 34-38. https://irjponline.org/index.php/irjp/article/view/3116